Endocrinology, Vol 127, 1640-1645, Copyright © 1990 by Endocrine Society

ARTICLES

Dexamethasone inhibits insulin biosynthesis by destabilizing insulin messenger ribonucleic acid in hamster insulinoma cells

J Philippe and M Missotten
Dept of Microbiology, Centre Medical Universitaire, Geneva, Switzerland.

Glucocorticoid effects on insulin biosynthesis and secretion have been controversial. To define whether glucocorticoids affect insulin biosynthesis in vitro, the actions of dexamethasone on insulin gene expression were examined using the HIT cell line, a transformed clonal line of hamster beta-cells. Dexamethasone induced a dose-dependent decrease in steady-state insulin messenger RNA (mRNA) levels, which was prevented by adding an excess of RU 486, a competitive inhibitor for the binding to the glucocorticoid receptor. Inhibition was not observed before 6 h of dexamethasone treatment and was maximal at 24 h. To further assess the molecular mechanisms of the dexamethasone-induced decreases in insulin mRNA levels, we investigated whether transcription of the insulin gene was affected. Run-on assays revealed that transcription rates were not changed by glucocorticoids. Inhibition of RNA and protein synthesis by actinomycin D and cycloheximide, respectively, completely abolished the dexamethasone effects, whereas actinomycin D added 9 h after dexamethasone had no effect on insulin mRNA levels. The present results demonstrate that glucocorticoids can acutely inhibit insulin biosynthesis by destabilizing insulin mRNA; this effect requires the transcriptional activation of a gene encoding a protein responsible for the accelerated disappearance of insulin mRNA.

This article has been cited by other articles:

				J. L. Larsen Pancreas Transplantation: Indications and Consequences Endocr. Rev., December 1, 2004; 25(6): 919 - 946. [Abstract] [Full Text] [PDF]

				R. P. Robertson Islet Transplantation as a Treatment for Diabetes -- A Work in Progress N. Engl. J. Med., February 12, 2004; 350(7): 694 - 705. [Full Text] [PDF]

				J. Shao, L. Qiao, and J. E. Friedman Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6 {beta}-cells Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E304 - E310. [Abstract] [Full Text] [PDF]

				K. R. Kritsch, S. Murali, M. L. Adamo, and D. M. Ney Dexamethasone decreases serum and liver IGF-I and maintains liver IGF-I mRNA in parenterally fed rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R528 - R536. [Abstract] [Full Text] [PDF]

				A. J. Weinhaus, N. V. Bhagroo, T. C. Brelje, and R. L. Sorenson Dexamethasone Counteracts the Effect of Prolactin on Islet Function: Implications for Islet Regulation in Late Pregnancy Endocrinology, April 1, 2000; 141(4): 1384 - 1393. [Abstract] [Full Text] [PDF]

				M. Poon, B. Liu, and M. B. Taubman Identification of a Novel Dexamethasone-Sensitive RNA-Destabilizing Region on Rat Monocyte Chemoattractant Protein 1 mRNA Mol. Cell. Biol., October 1, 1999; 19(10): 6471 - 6478. [Abstract] [Full Text] [PDF]

				U. Myrsen-Axcrona, S. Karlsson, F. Sundler, and B. Ahren Dexamethasone Induces Neuropeptide Y (NPY) Expression and Impairs Insulin Release in the Insulin-producing Cell Line RINm5F. RELEASE OF NPY AND INSULIN THROUGH DIFFERENT PATHWAYS J. Biol. Chem., April 18, 1997; 272(16): 10790 - 10796. [Abstract] [Full Text] [PDF]

				S. Gremlich, R. Roduit, and B. Thorens Dexamethasone Induces Posttranslational Degradation of GLUT2 and Inhibition of Insulin Secretion in Isolated Pancreatic beta Cells. COMPARISON WITH THE EFFECTS OF FATTY ACIDS J. Biol. Chem., February 7, 1997; 272(6): 3216 - 3222. [Abstract] [Full Text] [PDF]

				M. N.ėl. Chobert, G. Grondin, A. Brouillet, Y. Laperche, and A. R. Beaudoin Control of [IMAGE]-Glutamyl Transpeptidase Expression by Glucocorticoids in the Rat Pancreas J. Biol. Chem., May 24, 1996; 271(21): 12431 - 12437. [Abstract] [Full Text] [PDF]